Category: R&D

Scientist.com Raises $24M for “Pharma Markets” that Outsource R&D

San Diego’s Scientist.com set out in 2006 to disrupt part of the pharmaceutical business by providing an Amazon-like approach to the business of hiring contract research organizations (CROs). The company, which operates a network of online markets for outsourcing biomedical research services and supplies, has raised $24 million in a new round of venture funding. […] http://www.xconomy.com/san-diego/2017/05/15/scientist-com-raises-24m-for-pharma-markets-that-outsource-rd/

Merck advances R&D strategy through unique development model with Avillion for Anti IL-17 A/F Nanobody

Merck, a leading science and technology company, today announced a development agreement with Avillion, a UK-based company focused on increasing R&D output through innovative models, for anti IL-17 A/F Nanobody®. Merck’s Anti IL-17 A/F Nanobody® is an investigational therapy which has completed Phase I development, and is expected to begin Phase II in plaque psoriasis in 2017. http://www.worldpharmanews.com/merckgroup/3878-merck-advances-r-d-strategy-through-unique-development-model-with-avillion-for-anti-il-17-a-f-nanobody